STOCK TITAN
  1. Home
  2. Sec-filings
  3. HIMS
  4. [8-K] Hims & Hers Health, Inc. Reports Material Event

Hims & Hers Health (NYSE: HIMS) plans CAO Becklund exit

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Hims & Hers Health, Inc. announced that Irene BecklundChief Accounting OfficerPrincipal Accounting Officer

Becklund has served as Chief Accounting Officer since April 2025 and as Principal Accounting Officer since November 2021. The company entered into an advisory agreement with her, effective October 10, 2026, under which she will continue supporting the company in an advisory capacity through July 10, 2027.

Positive

  • None.

Negative

  • None.

Filing Explained

The filing states that Irene Becklund intends to resign as Chief Accounting Officer and Principal Accounting Officer effective October 9, 2026; her support after October 10, 2026 will therefore be in an advisory capacity rather than in those officer roles.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Notice of resignation date July 13, 2026 Date Irene Becklund informed the company of her intention to resign
Resignation effective date October 9, 2026 Effective date of Becklund’s resignation as CAO and Principal Accounting Officer
Advisory agreement start October 10, 2026 Start date of Becklund’s advisory agreement with the company
Advisory agreement end July 10, 2027 End date through which Becklund will support the company in an advisory role
CAO service since April 2025 Month and year Becklund began serving as Chief Accounting Officer
Principal Accounting Officer service since November 2021 Month and year Becklund began serving as Principal Accounting Officer
Chief Accounting Officer financial
"Ms. Becklund has served as the Company’s Chief Accounting Officer since April 2025"
A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.
Principal Accounting Officer financial
"the Company’s Principal Accounting Officer since November 2021"
The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.
Emerging growth company regulatory
"405) or Rule 12b-2 of the Securities Exchange Act of 1934 ... Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
advisory agreement financial
"The Company has entered into an advisory agreement with Ms. Becklund"
An advisory agreement is a written contract that spells out the responsibilities, fees and length of time a company hires an outside advisor — such as a financial, strategic or legal consultant — to provide ongoing guidance. For investors, it matters because the agreement sets costs, performance expectations, and any limits or conflicts that can affect a company’s strategy and financial results, similar to seeing the terms of a hired expert before judging their influence.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

What executive change did HIMS report in this Form 8-K?
Hims & Hers Health, Inc. reported that Irene BecklundChief Accounting OfficerPrincipal Accounting OfficerOctober 9, 2026. She informed the company of her intention to resign on July 13, 2026.

When does Irene Becklund’s resignation at HIMS become effective?
Irene Becklund’s resignation as Chief Accounting Officer and Principal Accounting Officer becomes effective on October 9, 2026. She will then transition to an advisory role starting October 10, 2026, continuing to support the company for several more months.

Is Irene Becklund leaving HIMS due to accounting or financial reporting disagreements?
No. Irene Becklund indicated that her resignation is not the result of any dispute or disagreement with Hims & Hers Health regarding its accounting principles, practices, or its financial statements and disclosures.

What role will Irene Becklund have at HIMS after resigning as CAO?
After resigning on October 9, 2026, Irene Becklund will continue under an advisory agreement effective October 10, 2026, supporting Hims & Hers Health in an advisory capacity until July 10, 2027.

How long has Irene Becklund served in senior accounting roles at HIMS?
Irene Becklund has served as the company’s Principal Accounting Officer since November 2021 and as Chief Accounting Officer since April 2025. Her upcoming resignation ends several years in these senior accounting positions.

Does HIMS classify as an emerging growth company in this filing?
The disclosure references the status of an emerging growth company under the Securities Exchange Act rules. This classification relates to certain reduced reporting and compliance requirements available to qualifying issuers like Hims & Hers Health.
0001773751false00017737512026-05-292026-05-29

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________________________________________________________________________________________

FORM 8-K
_____________________________________________________________________________________________________________________

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 13, 2026
_____________________________________________________________________________________________________________________

HIMS & HERS HEALTH, INC.
(Exact name of registrant as specified in its charter)
_____________________________________________________________________________________________________________________

Delaware 001-38986 98-1482650
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
2269 Chestnut Street, #523
San Francisco, CA 94123
(Address of principal executive offices)
(415) 851-0195
(Registrant’s telephone number, including area code)
______________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbolName of each exchange on which registered
Class A Common Stock, $0.0001 par value HIMS New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). 

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On July 13, 2026, Irene Becklund informed Hims & Hers Health, Inc. (the “Company”) of her intention to resign as Chief Accounting Officer and Principal Accounting Officer, effective as of October 9, 2026. Ms. Becklund has indicated to the Company that her resignation is not the result of any dispute or disagreement with the Company’s accounting principles or practices or financial statements and disclosures. Ms. Becklund has served as the Company’s Chief Accounting Officer since April 2025 and the Company’s Principal Accounting Officer since November 2021. The Company has entered into an advisory agreement with Ms. Becklund, effective as of October 10, 2026, pursuant to which Ms. Becklund will continue to support the Company until July 10, 2027.


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

HIMS & HERS HEALTH, INC.
Date: July 17, 2026By:/s/ Andrew Dudum
Andrew Dudum
Chief Executive Officer


Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents